Answers are grounded in this paper and cite their sources.
Competition feeding experiments performed in vivo have identified 1 as the true starter unit for the rapamycin polyketide synthase, and indicate its potential application for generating novel analogues of this clinically important immunosuppresant molecule.
No takes yet. Share an insight, caveat, or question.
Lowden et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: